Discovery to Cure
The innovative program known as Discovery to Cure: Advancing the Prevention, Early Detection & Treatment of Women's Reproductive Cancers was launched in 2003 to provide women with new methods for the prevention, early detection and treatment of gynecologic cancers. Epithelial ovarian cancer (EOC) is the fourth leading cause of cancer-related death in women in the United States and leading cause of gynecologic cancer death. Although it is only 20 percent as common as breast cancer, its mortality rate is three times as high. It is estimated that one in 57 women will develop ovarian cancer in her lifetime. On average 21,000 new cases are diagnosed annually and 15,000 women die of the disease. This is because with few and vague early symptoms the disease often passes under the medical radar until it has reached later stages of malignancy and therapeutic options become limited.
It is for this reason that the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale University created the comprehensive women's reproductive cancer clinical care and early detection program known as Discovery to Cure to lead the way in developing and providing novel methodologies and treatments of ovarian and other gynecologic cancers. It is the direct connection between the laboratory and the clinic that makes Discovery to Cure truly unique. The laboratory efforts include molecular and cellular research and clinical trials focusing on new treatments and approaches to diagnosis and prevention.
It is for this reason that the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale University created the comprehensive women's reproductive cancer clinical care and early detection program known as Discovery to Cure to lead the way in developing and providing novel methodologies and treatments of ovarian and other gynecologic cancers. It is the direct connection between the laboratory and the clinic that makes Discovery to Cure truly unique. The laboratory efforts include molecular and cellular research and clinical trials focusing on new treatments and approaches to diagnosis and prevention.
Discovery to Cure Programs
Yale Early Detection Program For Ovarian Cancer
The Early Detection Program tests and puts into practice novel approaches for screening women's reproductive cancers.
The clinical program is committed to providing a comprehensive approach to treating reproductive cancer.
The Discovery to Cure Gala
Drs. Silasi, Mor, Rutherford, Azodi, Santin, Ratner and Schwartz
Survivor Amy Gaulin inspired the audience with her story
Dr. Tom Rutherford, Howard Thompson, Beth Gargano-Thompson, Cokie Roberts, Stephanie Ercegovic and Jacques Dickinson
Dr. Gil Mor and IreneVisintin
Co-Chairs Jacques Dickinson and Stephanie Ercegovic and Dr. Tom Rutherford
Event Planners Extraordinaire, Paulomi Aldo and Michele Montagna
The Flamingos
Jim and Wendy Long with Cokie Roberts
Discovery to Cure Patient Advocates
Dr. Rutherford and Cokie Roberts
Dr. & Mrs. Peter Schwartz and Dr. Charles Lockwood
Dr. & Mrs. Gil Mor with Cokie Roberts
Drs. Rutherford and Schwartz
Dr. Tavassoli and husband, Dr. & Mrs. Alessandro Santin
The Stamford Marriott Ballroom
